INE790G01031
INE790G01031
SHILPA MEDICARE LTD.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 199.56B EUR | 117.02B EUR | 68.19B EUR | 60.68B EUR |
Enterprise Value | 205.63B EUR | 117.02B EUR | 74.38B EUR | 60.68B EUR |
Valuation Multiples | ||||
Trailing P/E | 72.06x | 39.36x | 28.02x | 44.77x |
Forward P/E | 48.91x | -- | -- | -- |
Price to Sales | 11.86x | 6.96x | 4.43x | 5.51x |
Price to Book | 7.7x | -- | 2.63x | -- |
EV/Revenue | 12.22x | 6.96x | 4.84x | 5.51x |
EV/EBITDA | 43.25x | 22.96x | 16.11x | 18.85x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |